The company currently trades on the Canadian Securities Exchange, where its market performance has been aggressive. Shares have climbed more than 52% since January, finishing Monday’s session at 18.15 Canadian dollars, or roughly $13.01. This repurchase initiative coincides with the firm’s transition toward major U.S. exchange exposure, marking a significant milestone as the first cannabis entity to receive such approval. Management retains the flexibility to execute these buybacks over the coming twelve-month window, signaling confidence in the current valuation as the company prepares to shift its primary trading venue.
Trulieve Cannabis Authorizes $50 Million Share Repurchase Program
Trulieve Cannabis will deploy $50 million to buy back its own shares over the next year, a strategic move following its landmark regulatory clearance to list on the New York Stock Exchange. The board’s authorization targets the cancellation of approximately 8.5 million shares by June 16, 2025.
Comments (0)
No comments yet. Be the first!